<DOC>
	<DOC>NCT00989599</DOC>
	<brief_summary>To verify the efficacy of topical applications of Chamomilla recutita infusion for phlebitis treatment, before dose response curve study and pilot study.</brief_summary>
	<brief_title>Use of Chamomilla Recutita in Phlebitis</brief_title>
	<detailed_description>The hypothesis adopted was that patients with phlebitis due to peripheral intravenous infusion in anti-neoplasm chemotherapy, treated with a compress of Chamomilla recutita infusion for 20 minutes three times per day, would present a shorter phlebitis regression time in comparison with patients treated with a lukewarm water compress.</detailed_description>
	<mesh_term>Phlebitis</mesh_term>
	<criteria>Subjects with cancer who had infusion phlebitis during the administration of intravenous chemotherapy peripheral under hospitalization. Report made by the subject of study, prior hypersensitivity reaction or presentation during the research, adverse reaction to chamomile or any plant of the family Asteraceae ou Compositae: margarida (Aster tripolium), crisântemo (Chrysanthemum leucanthemum), artemísia or isopo santo (Artemísia vulgaris), carpineira or ambrósia americana (Ambrosia artemisiifolia) and senécio (Senecio jacobaea L.); Prescription during the process of data collection, some kind of antiinflammatory with systemic or topical activity where it was located phlebitis, and, upon the occurrence of bacterial phlebitis, had been prescribed topical or systemic antibiotic therapy; Refusal of the subject to participate in the study, regardless of the time.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>phlebitis</keyword>
	<keyword>Chamomilla recutita</keyword>
	<keyword>Catheterization peripheral</keyword>
</DOC>